Fidelity Investments’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298M | Buy |
18,599,195
+1,358,160
| +8% | +$21.7M | 0.02% | 668 |
|
|
2025
Q1 | $295M | Buy |
17,241,035
+4,143,120
| +32% | +$70.8M | 0.02% | 660 |
|
|
2024
Q4 | $324M | Buy |
13,097,915
+560,344
| +4% | +$13.9M | 0.02% | 632 |
|
|
2024
Q3 | $357M | Buy |
12,537,571
+2,053,688
| +20% | +$58.6M | 0.02% | 599 |
|
|
2024
Q2 | $277M | Buy |
10,483,883
+2,827,938
| +37% | +$74.7M | 0.02% | 663 |
|
|
2024
Q1 | $247M | Sell |
7,655,945
-219,877
| -3% | -$7.1M | 0.02% | 714 |
|
|
2023
Q4 | $332M | Buy |
7,875,822
+127,276
| +2% | +$5.36M | 0.03% | 559 |
|
|
2023
Q3 | $297M | Buy |
7,748,546
+2,494,678
| +47% | +$95.8M | 0.03% | 561 |
|
|
2023
Q2 | $99.7M | Buy |
5,253,868
+1,106,899
| +27% | +$21M | 0.01% | 994 |
|
|
2023
Q1 | $64.3M | Buy |
4,146,969
+1,658,836
| +67% | +$25.7M | 0.01% | 1157 |
|
|
2022
Q4 | $44.2M | Buy |
2,488,133
+2,487,410
| +344,040% | +$44.2M | ﹤0.01% | 1302 |
|
|
2022
Q3 | $4K | Buy |
723
+23
| +3% | +$127 | ﹤0.01% | 4391 |
|
|
2022
Q2 | $3K | Sell |
700
-193
| -22% | -$827 | ﹤0.01% | 4460 |
|
|
2022
Q1 | $5K | Buy |
+893
| New | +$5K | ﹤0.01% | 4437 |
|
|
2020
Q4 | – | Sell |
-200,000
| Closed | -$7.04M | – | 4070 |
|
|
2020
Q3 | $7.04M | Buy |
+200,000
| New | +$7.04M | ﹤0.01% | 1949 |
|